In a significant show of legal unity, Massachusetts Attorney General Andrea Joy Campbell has rallied with counterparts from 23 other states, forming a coalition aimed at preserving nationwide access to medication abortions. As reported by the Massachusetts government's official website, this alliance is aggressively pushing back against the reinstatement of previously lifted restrictions on the FDA-approved abortion pill, mifepristone, by the controversial Fifth Circuit Court of Appeals.
The amicus brief the coalition submitted argues that this type of restriction could have a deleterious effect, particularly on vulnerable groups, citing the court's ruling as a blatant disregard for decades of evidence that unquestionably establish mifepristone as both safe and effective. "The lower court’s decision ignores decades of evidence that shows mifepristone is safe and effective by reinstating severe restrictions on access to mifepristone, which will make it even harder for patients to obtain abortion care in post-Dobbs America," AG Campbell declared in a statement obtained by Mass.gov. The AG's stance is clear: The coalition seeks to reverse the Fifth Circuit's decision and preserve the critical role mifepristone plays in affording bodily autonomy.
The brief emphasizes that if the Fifth Circuit's ruling stood, it would spell chaos for those seeking the most common method of abortion and disrupt the larger healthcare system. The ripple effect, as the attorney generals argue, extends beyond the immediate repercussions for individuals—with post-Dobbs America already facing severe limitations on abortion access, reinforcing these hurdles could drive many towards unnecessary and more invasive procedures, inflate costs, and deny countless Americans this critical aspect of healthcare.
This isn't the first foray for AG Campbell in the fight for reproductive rights. Since assuming office, she has established Massachusetts as a stronghold for reproductive justice, evidenced by the launch of an Abortion Legal Hotline and the initiation of a $1.5 million grant program focused on maternal health disparities. Moreover, her establishment of the dedicated Reproductive Justice Unit underscores her office's commitment to a comprehensive approach in this domain. All this, amid an era of heightened national contest over reproductive care, marks the Commonwealth's enduring resolve to champion reproductive freedoms.
With the likes of Arizona, California, Colorado, Connecticut, Delaware, Hawai‘i, Illinois, Maine, Maryland, Michigan, Minnesota, Nevada, New Jersey, New Mexico, New York, North Carolina, Oregon, Pennsylvania, Rhode Island, Vermont, Washington, Wisconsin, and the District of Columbia in their ranks, Massachusetts and AG Campbell stand united against a ruling that many see as a direct challenge to the FDA’s ability to decide on drug safety and medical necessity based on science and data.
